摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-2-(3-((3-(isoquinolin-5-ylamino)pyrrolidin-1-yl)methyl)phenoxy)ethanol L-tartaric acid salt | 1202274-97-2

中文名称
——
中文别名
——
英文名称
(R)-2-(3-((3-(isoquinolin-5-ylamino)pyrrolidin-1-yl)methyl)phenoxy)ethanol L-tartaric acid salt
英文别名
(2R,3R)-2,3-dihydroxybutanedioic acid;2-[3-[[(3R)-3-(isoquinolin-5-ylamino)pyrrolidin-1-yl]methyl]phenoxy]ethanol
(R)-2-(3-((3-(isoquinolin-5-ylamino)pyrrolidin-1-yl)methyl)phenoxy)ethanol L-tartaric acid salt化学式
CAS
1202274-97-2
化学式
C4H6O6*C22H25N3O2
mdl
——
分子量
513.547
InChiKey
KQKVSPBZUIEMDL-AOSJBURYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.17
  • 重原子数:
    37
  • 可旋转键数:
    10
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    173
  • 氢给体数:
    6
  • 氢受体数:
    11

反应信息

点击查看最新优质反应信息

文献信息

  • PROCESS FOR THE PREPARATION OF RHO-KINASE INHIBITOR COMPOUNDS
    申请人:She Jin
    公开号:US20100022775A1
    公开(公告)日:2010-01-28
    The present invention is directed to practical high-yielding synthetic processes to prepare compounds of general Formula III, IV, V, VII, VIII, IX, X, XII, XIV, and XV. Such compounds are useful as final products or can be used as intermediates and be further modified to prepare other desired products such as rho-kinase inhibitors. The present invention is also directed to certain novel compounds and/or novel solid forms of certain compounds.
    本发明涉及实用的高产率合成过程,用于制备通式III、IV、V、VII、VIII、IX、X、XII、XIV和XV的化合物。这些化合物可用作最终产品,也可用作中间体,并进一步改性以制备其他所需产品,如rho-激酶抑制剂。本发明还涉及某些新颖化合物和/或某些化合物的新颖固态形式。
  • Process for the preparation of Rho-kinase inhibitor compounds
    申请人:Inspire Pharmaceuticals, Inc.
    公开号:US08158796B2
    公开(公告)日:2012-04-17
    The present invention is directed to practical high-yielding synthetic processes to prepare compounds of general Formula III, IV, V, VII, VIII, IX, X, XII, XIV, and XV. Such compounds are useful as final products or can be used as intermediates and be further modified to prepare other desired products such as rho-kinase inhibitors. The present invention is also directed to certain novel compounds and/or novel solid forms of certain compounds.
    本发明旨在提供实用的高产率合成过程,以制备通式III、IV、V、VII、VIII、IX、X、XII、XIV和XV的化合物。这些化合物可用作最终产品,也可以用作中间体,并进一步改性以制备其他所需产品,如Rho激酶抑制剂。本发明还涉及某些新颖化合物和/或某些化合物的新颖固体形式。
  • [EN] PROCESS FOR THE PREPARATION OF RHO-KINASE INHIBITOR COMPOUNDS<br/>[FR] PROCESSUS DE PRÉPARATION DE COMPOSÉS INHIBITEURS DE RHO-KINASE
    申请人:INSPIRE PHARMACEUTICALS INC
    公开号:WO2009154940A1
    公开(公告)日:2009-12-23
    The present invention is directed to practical high-yielding synthetic processes to prepare compounds of general Formula III, IV, V, VII, VIII, IX, X, XII, XIV, and XV. Such compounds are useful as final products or can be used as intermediates and be further modified to prepare other desired products such as rho-kinase inhibitors. The present invention is also directed to certain novel compounds and/or novel solid forms of certain compounds.
    本发明旨在提供实用的高产率合成工艺,用于制备一般化学式III、IV、V、VII、VIII、IX、X、XII、XIV和XV的化合物。这些化合物可用作最终产品,也可用作中间体,并可进一步修改以制备其他所需产品,如rho-激酶抑制剂。本发明还涉及某些新颖化合物和/或某些化合物的新颖固体形式。
查看更多